0001567619-23-000919.txt : 20230113
0001567619-23-000919.hdr.sgml : 20230113
20230113164909
ACCESSION NUMBER: 0001567619-23-000919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230112
FILED AS OF DATE: 20230113
DATE AS OF CHANGE: 20230113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Devin Whittemore
CENTRAL INDEX KEY: 0001747818
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 23529291
MAIL ADDRESS:
STREET 1: C/O MINERVA NEUROSCIENCES, INC.
STREET 2: 1601 TRAPELO ROAD, SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
doc1.xml
FORM 4
X0306
4
2023-01-12
0
0001865494
IO Biotech, Inc.
IOBT
0001747818
Smith Devin Whittemore
C/O IO BIOTECH, INC.
OLE MAALOES VEH 3
COPENHAGEN
G7
2200
DENMARK
0
1
0
0
General Counsel
Stock Option (Right to Buy)
2.60
2023-01-12
4
A
0
150000
0
A
2033-01-12
Common Stock
150000
150000
D
One-fourth of these options vest on January 12, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.
/s/ Brian Burkavage, Attorney-in-Fact for Devin W. Smith
2023-01-13